Q1 2025 · 13F-HR
NEA Management Company, LLCholdings as filed
Filed 2025-05-14 · accession 0000897069-25-000979
$1.30B
Reported value
38
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $245.7M | 18.9% | 3,745,262 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $170.7M | 13.1% | 2,688,565 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $154.1M | 11.9% | 2,909,956 | Common | SOLE |
| 88023B103 | TEM | TEMPUS AI INC | $126.2M | 9.72% | 2,615,979 | Common | SOLE |
| 22266M104 | COUR | COURSERA INC | $85.7M | 6.60% | 12,867,769 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $71.5M | 5.51% | 11,370,376 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $67.8M | 5.22% | 24,471,264 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $54.0M | 4.16% | 1,587,854 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $35.7M | 2.75% | 7,692,298 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $31.9M | 2.46% | 3,969,834 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $26.7M | 2.05% | 3,614,486 | Common | SOLE |
| 126638105 | CVRX | CVRX INC | $24.8M | 1.91% | 2,026,083 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $20.7M | 1.59% | 2,613,948 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $19.9M | 1.53% | 18,093,034 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $19.0M | 1.46% | 1,090,793 | Common | SOLE |
| 10920V404 | — | NEUEHEALTH INC | $18.4M | 1.42% | 2,726,917 | Common | SOLE |
| 15870P307 | CSBR | CHAMPIONS ONCOLOGY INC | $14.9M | 1.15% | 1,713,720 | Common | SOLE |
| 81726A209 | — | SENTI BIOSCIENCES INC | $12.7M | 0.98% | 3,775,615 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $12.6M | 0.97% | 1,250,001 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $12.3M | 0.95% | 1,960,169 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $12.3M | 0.94% | 2,195,545 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $11.3M | 0.87% | 6,467,802 | Common | SOLE |
| 25058X303 | DM* | DESKTOP METAL INC | $7.1M | 0.54% | 1,439,892 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $6.9M | 0.53% | 4,448,757 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $6.6M | 0.51% | 3,568,781 | Common | SOLE |
| 12430A300 | BZFD | BUZZFEED INC | $5.4M | 0.41% | 2,512,103 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $4.3M | 0.33% | 1,462,586 | Common | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $3.6M | 0.28% | 2,922,772 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $3.5M | 0.27% | 14,986,793 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $3.4M | 0.26% | 17,079,778 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $2.2M | 0.17% | 2,437,689 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $2.1M | 0.16% | 478,548 | Common | SOLE |
| 57055L206 | MRKR | MARKER THERAPEUTICS INC | $2.0M | 0.15% | 1,625,678 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $1.4M | 0.11% | 6,147,260 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $768,081 | 0.06% | 600,063 | Common | SOLE |
| N01045207 | AFMDQ | AFFIMED N V | $320,123 | 0.02% | 442,648 | Common | SOLE |
| 96328L205 | 2CH | WHEELS UP EXPERIENCE INC | $107,186 | 0.01% | 106,125 | Common | SOLE |
| 90114C107 | TUYA | TUYA INC | $0 | — | 0 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.